Home    >    Press Releases    >    Euthymics Bioscience, Inc. Presents Phase II Data For EB-1010 In Major Depression At ACNP Annual Meeting

Euthymics Bioscience, Inc. Presents Phase II Data For EB-1010 In Major Depression At ACNP Annual Meeting

Data Among the First Positive Evidence for the Role of Triple Reuptake Inhibitors in Depression

 

Press_Release-PH II_DATA_ACNP_120710_FINAL